David M. Savastano, Phd is a Medical & Scientific Affairs Leader at Currax Pharmaceuticals LLC. Colleagues describe them as "I had the opportunity to work with David during his time at Helsinn. As the medical affairs lead for a product launch, David quickly onboarded to a new therapeutic area, and I relied on his strong command of the clinical data, strategic thinking and resourcefulness. We worked on many projects together including strategic planning, insight gathering, developing brand communication materials, and training content. He is a collaborative medical affairs partner, and routinely delivered results against tight timelines. What sets David apart is his ability to dive deep into complex science and data, yet communicate key insights clearly and simply to both internal teams and external audiences. David brought a well-rounded perspective and I valued his input and expertise." and "David is a highly skilled medical affairs and clinical development professional. I’ve had the pleasure of working with him at both Pfizer and Helsinn. He is one of the few colleagues I’ve worked with over the years who has experience with the full breadth and depth of both disciplines in a few different therapeutic categories. He has independently taken on the medical tasks associated with an oncology launch, and rapidly engaged and developed strong connections with external experts that resulted in cutting edge publications that demonstrated important benefit/risk attributes of a new product. While at Pfizer he developed new clinical programs, had numerous FDA engagements with the creation of complex briefing materials for several different products. David also led a team of clinical research life science doctorates and was able to keep multiple programs going at once while maintaining high ratings by peers and reports alike in all of the Pfizer 360 annual feedback sessions. For these reasons and more David has my complete endorsement."